
|Articles|September 1, 2003
Pfizer competitors quietly explore surgical business
New York-Potential suitors are lining up to express interest in the probable sale of Pfizer Inc.'s surgical ophthalmology business, but so far, no one is proposing-publicly.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
3
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5















































.png)


